Latest Market News

Jan 04
Press release on the reopening of trading in Integrale

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Integrale (Tier 2 notes 6,25% due January 2025), ISIN BE0002220862, on Euronext Brussels will re-open on 23/08/2021 at 09:00 CET. Source: FSMA

Jan 04
Press release on the reopening of trading in Emakina Group

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Emakina Group, ISIN BE0003843605 on Euronext Brussels will re-open on 19/8/2021 at 11:30 CET. Source: FSMA

Jan 04
Exelon stock falls from near 13-year peak after analyst downgrades, citing BBB uncertainty

Shares of Exelon Corp. EXC, -1.19% pulled back 2.7% in afternoon trading Monday, putting them on track to snap an eight-session win streak, after Mizuho analyst Paul Fremont downgraded the utility services holding company, citing an uncertain outlook for President Biden’s “Build Back Better” plan. The stock had rallied 8.2% during the streak to close […]

Jan 04
Gold futures mark lowest finish in nearly 2 weeks

Gold futures declined on Monday, with strength in U.S. Treasury yields and the stock market contributing to a fall in prices for the precious metal to their lowest settlement in almost two weeks. The yield on the 10-year Treasury note TMUBMUSD10Y, 1.632% topped 1.6% Monday to touch the highest level since November. Against that backdrop, […]

Jan 04
American Airlines stock surges toward 6-week high amid a broad airline-sector rally

Share of air carriers traded broadly higher Monday, amid growing optimism that the latest surge in COVID-19 cases to record daily levels won’t lead to widespread shutdowns given the omicron variant appears less severe and as more people are vaccinated. The U.S. Global Jets ETF JETS, +3.22% rallied 2.8% in afternoon trading, to outperform the […]

Jan 04
Genprex stock more than doubles on very heavy volume after FTD granted for cancer treatment

Shares of Genprex Inc. GNPX, +167.18% skyrocketed 121% on massive volume in afternoon trading Monday, after the gene therapy company said its Reqorsa Immunogene Therapy was granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration for use in combination with Merck & Co. Inc.’s MRK, +0.30% cancer treatment Keytruda. Trading volume exploded […]